KR20030094388A - 마가이닌 유도체 - Google Patents
마가이닌 유도체 Download PDFInfo
- Publication number
- KR20030094388A KR20030094388A KR10-2003-7014458A KR20037014458A KR20030094388A KR 20030094388 A KR20030094388 A KR 20030094388A KR 20037014458 A KR20037014458 A KR 20037014458A KR 20030094388 A KR20030094388 A KR 20030094388A
- Authority
- KR
- South Korea
- Prior art keywords
- marganine
- lys
- derivative
- margarine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
시약 | 용량 |
물 | 0.50ml |
메틸 페네이트 | 0.50ml |
페놀 | 0.75g |
머캡토에탄올 | 0.20ml |
트리플루오로아세트산 | 10.0ml |
샘플 | 농도㎍/ml | 남은 박테리아 콜로니 | 사멸된 박테리아 % | |||
0hr | 3hr | 4hr | 3hr | 4hr | ||
실시예1로부터 얻어진 마가이닌 유도체 | 0 | 407 228 | ||||
317 | ||||||
10 | 109 73 | 160 195 | 71.3 | 44.2 | ||
91 | 177 | |||||
20 | 9 5 | 2 5 | 97.8 | 99.1 | ||
7 | 3 | |||||
자연 발생적 마가이닌 II | 10 | 99 57 | 52 44 | 75.4 | 84.9 | |
78 | 48 | |||||
20 | 12 4 | 6 4 | 97.5 | 99.2 | ||
8 | 5 |
농도㎍/ml | 남은 박테리아 콜로니 | 2시간 이내에 사멸된 박테리아 % | ||
0hr | 1hr | 2hr | ||
0 | 267 | |||
225 | ||||
50 | 158 | 18 | 2 | 99 |
185 | 18 | 2 | 99 | |
172 | 18 | 2 | 99 |
그룹 | 용량(㎍/ml) | 용혈% | |
테스트 그룹 | 자연-발생적 마가이닌 | 100 | 0 |
500 | 0 | ||
1000 | 1.9 | ||
실시예1로부터 제조된 마가이닌 유도체 | 100 | 0 | |
500 | 0 | ||
1000 | 2 | ||
콘트롤 그룹 | Tritonx-100 | 0.1% | 100 |
복부 주입량 | 생존율 |
100㎍ | 100% |
200㎍ | 100% |
1000㎍ | 100% |
Claims (4)
- 서열번호 1(서열목록의 <210>1)의 아미노산 서열을 갖는 마가이닌 유도체 및 약제학적으로 허용되는 그 염.
- 바이오엔지니어링 테크닉에 의해 제1항에 따른 마가이닌 유도체를 생산하는 방법으로서,마가이닌 유도체의 아미노산 서열에 따라 유전자 단편들을 합성하는 단계;상기 유전자 단편들을 라이게이션시키는 단계;재조합 플라스미드를 제조하고 클로닝하는 단계; 및발효, 분리, 정제 및 동결건조를 통해 산물을 얻는 단계를 포함하는 것을 특징으로 하는 마가이닌 유도체의 생산방법.
- 고상 합성에 의해 제1항에 따른 마가이닌 유도체를 생산하는 방법으로서,고상 캐리어로서 HMP 수지를 이용하고,아미노산의 알파-아민을 9-플루오르에닐 메톡시카르보닐(Fmoc)로 보호하고,펩티드 합성기 상에서 합성하고,분리, 정제 및 동결건조를 통해 산물을 얻는 것을 포함하는 것을 특징으로 하는 마가이닌 유도체의 생산방법.
- 항-미생물 작용을 갖는 의약의 제조에 있어서 제1항에 따른 마가이닌 유도체 및 약제학적으로 허용되는 그 염의 용도.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011128550A CN1158304C (zh) | 2001-05-10 | 2001-05-10 | 蛙皮抗菌肽衍生物 |
CN01112855.0 | 2001-05-10 | ||
PCT/CN2002/000317 WO2003016339A1 (en) | 2001-05-10 | 2002-05-08 | A frog skin antibacterial peptide derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030094388A true KR20030094388A (ko) | 2003-12-11 |
KR100902209B1 KR100902209B1 (ko) | 2009-06-11 |
Family
ID=4659602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037014458A KR100902209B1 (ko) | 2001-05-10 | 2002-05-08 | 마가이닌 유도체 |
Country Status (9)
Country | Link |
---|---|
US (2) | US7232800B2 (ko) |
EP (1) | EP1386928B1 (ko) |
JP (1) | JP4194941B2 (ko) |
KR (1) | KR100902209B1 (ko) |
CN (1) | CN1158304C (ko) |
AU (1) | AU2002257498B2 (ko) |
BR (1) | BRPI0209684B8 (ko) |
CA (1) | CA2446848C (ko) |
WO (1) | WO2003016339A1 (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1158304C (zh) * | 2001-05-10 | 2004-07-21 | 上海华谊生物技术有限公司 | 蛙皮抗菌肽衍生物 |
US7550426B2 (en) * | 2005-05-18 | 2009-06-23 | Ghc Research Development Corporation | Acetylated therapeutic procytotoxins |
CN100575359C (zh) * | 2006-04-17 | 2009-12-30 | 中国科学院成都生物研究所 | 一种无指盘臭蛙抗菌肽及其用途 |
CN100522993C (zh) * | 2006-05-30 | 2009-08-05 | 中国科学院昆明动物研究所 | 无指盘臭蛙抗菌肽 |
CN101182360B (zh) * | 2007-10-08 | 2010-07-07 | 国家海洋局第一海洋研究所 | 一种具有抗菌功能的融合蛋白及其应用 |
CN101928340A (zh) * | 2009-12-24 | 2010-12-29 | 深圳市圣西马生物技术有限公司 | 一组抗菌肽衍生物及其应用 |
CN102796177A (zh) * | 2012-08-13 | 2012-11-28 | 中国科学院烟台海岸带研究所 | 一种改造体抗菌肽及其制备方法和应用 |
CN102786583B (zh) * | 2012-08-13 | 2014-03-19 | 中国科学院烟台海岸带研究所 | 一种昆嵛林蛙改造体抗菌肽及其制备方法和应用 |
GB201409451D0 (en) | 2014-05-28 | 2014-07-09 | Ipabc Ltd | Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms |
WO2018100408A1 (en) * | 2016-11-30 | 2018-06-07 | Sasinapas Co.,Ltd. | Modified peptides |
CN106749594B (zh) * | 2016-12-27 | 2020-02-14 | 王天放 | 包含f1、f3多肽的药物组合物及其在治疗hpv感染疾病中的应用 |
US11325955B2 (en) * | 2017-07-19 | 2022-05-10 | Dana-Farber Cancer Institute, Inc. | Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections |
CN110042138B (zh) * | 2019-04-10 | 2020-12-29 | 常熟理工学院 | 一种林蛙油抗氧化肽组分的制备方法及其分离方法与用途 |
CN116134045A (zh) * | 2021-09-03 | 2023-05-16 | 深圳千越生物科技有限公司 | 抗菌肽或肽衍生物、替换体以及其组合物、制备方法和应用 |
CN117643563B (zh) * | 2024-01-29 | 2024-03-29 | 广州首漾医药生物科技有限公司 | 一种抑菌除螨膏霜及制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5912231A (en) * | 1989-07-07 | 1999-06-15 | Scripps Clinic And Research Foundation | Substitution analogues of magainin peptides |
US5792831A (en) * | 1990-02-08 | 1998-08-11 | Magainin Pharmaceuticals Inc. | Analogues of magainin peptides containing D-amino acids |
US5654274A (en) * | 1992-06-01 | 1997-08-05 | Magainin Pharmaceuticals, Inc. | Biologically active peptides having N-terminal substitutions |
US5589364A (en) * | 1994-07-29 | 1996-12-31 | Magainin Pharmaceuticals Inc. | Recombinant production of biologically active peptides and proteins |
US6461834B1 (en) * | 1998-11-06 | 2002-10-08 | Bionebraska, Inc. | Clostripain catalyzed amidation of peptides |
EP1076066A1 (en) * | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
CN1158304C (zh) * | 2001-05-10 | 2004-07-21 | 上海华谊生物技术有限公司 | 蛙皮抗菌肽衍生物 |
-
2001
- 2001-05-10 CN CNB011128550A patent/CN1158304C/zh not_active Expired - Lifetime
-
2002
- 2002-05-08 WO PCT/CN2002/000317 patent/WO2003016339A1/zh active Application Filing
- 2002-05-08 JP JP2003521261A patent/JP4194941B2/ja not_active Expired - Lifetime
- 2002-05-08 BR BRPI0209684A patent/BRPI0209684B8/pt not_active IP Right Cessation
- 2002-05-08 CA CA2446848A patent/CA2446848C/en not_active Expired - Lifetime
- 2002-05-08 EP EP02727168.3A patent/EP1386928B1/en not_active Expired - Lifetime
- 2002-05-08 AU AU2002257498A patent/AU2002257498B2/en not_active Expired
- 2002-05-08 KR KR1020037014458A patent/KR100902209B1/ko active IP Right Grant
-
2003
- 2003-11-10 US US10/705,106 patent/US7232800B2/en not_active Expired - Lifetime
-
2007
- 2007-03-14 US US11/686,190 patent/US20070166790A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040197864A1 (en) | 2004-10-07 |
EP1386928B1 (en) | 2015-10-14 |
KR100902209B1 (ko) | 2009-06-11 |
AU2002257498B2 (en) | 2007-10-25 |
BRPI0209684B8 (pt) | 2021-05-25 |
BRPI0209684B1 (pt) | 2016-08-30 |
JP2005502663A (ja) | 2005-01-27 |
US7232800B2 (en) | 2007-06-19 |
US20070166790A1 (en) | 2007-07-19 |
BR0209684A (pt) | 2004-07-13 |
CA2446848C (en) | 2013-09-10 |
CA2446848A1 (en) | 2003-02-27 |
CN1363558A (zh) | 2002-08-14 |
WO2003016339A1 (en) | 2003-02-27 |
JP4194941B2 (ja) | 2008-12-10 |
EP1386928A4 (en) | 2005-04-13 |
EP1386928A1 (en) | 2004-02-04 |
CN1158304C (zh) | 2004-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100902209B1 (ko) | 마가이닌 유도체 | |
KR100902208B1 (ko) | 인슐린 친화성 펩티드 유도체 | |
Andreu et al. | N-terminal analogs of cecropin A: synthesis, antibacterial activity, and conformational properties | |
CA2052375C (en) | Parathyroid hormone derivatives | |
EP2518080B1 (en) | Antibiotic peptides | |
KR101046426B1 (ko) | 항균 펩타이드 및 이를 포함하는 항균 조성물 | |
JPH07291997A (ja) | 腫瘍壊死因子の突然変異体 | |
EP0646596B1 (de) | Nukleinsäure-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik | |
Machado et al. | Synthesis and properties of cyclic gomesin and analogues | |
AU2003302610A1 (en) | NOVEL Chi-CONOTOXIN PEPTIDES (-II) | |
US4703034A (en) | Novel cyclic tetrapeptide | |
EP0437556A4 (en) | Substitution analogues of magainin peptides | |
WO1998016549A1 (en) | Antimicrobial peptide analogs of gramicidin s and compositions comprising them | |
DK147944B (da) | Fremgangsmaade til fremstilling af biologisk aktive polypeptider som indeholder asparaginylgrupper | |
Ravdel et al. | 6-glycine-8-phenyllactic acid bradykinin. Its synthesis, biological activity, and splitting by kininase (carboxypeptidase N) | |
CA2118253A1 (en) | Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds | |
Gu et al. | Isolation and purification of novel anti-fungal peptides from hemolymph of immunized larvae of housefly, Musca domestica | |
KR20010052664A (ko) | 가교결합-안정화된 인돌리시딘 유사체 | |
You et al. | Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen | |
NL8301281A (nl) | Biologisch actieve peptiden. | |
RU2067870C1 (ru) | Противоопухолевое средство | |
CN118103387A (zh) | 肽 | |
EP0424512B1 (en) | Antimetastatic peptides | |
CN113874045A (zh) | 细胞层渗透促进剂、药剂吸收辅助用组合物及药物组合物 | |
NO771031L (no) | Produkter og fremgangsm}te til fremstilling av forbindelser for behandling av schizofreni. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130522 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140521 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150430 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160427 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170504 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180427 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190429 Year of fee payment: 11 |